Migraines are a common ailment worldwide, affecting nearly 15% of the global population. At times, they can be debilitating ...

Atogepant 60 mg once daily leads to meaningful weight loss in patients with overweight or obesity receiving preventive ...

Patients with migraine discontinued treatment less often with atogepant and experienced a greater reduction in mean monthly migraine days compared with topiramate, according to topline results from a ...

MR is associated with better treatment response than gepants in patients with migraine who previously had an inadequate response to gepants.

A 75% plus increase in good days/month with eptinezumab is associated with improved migraine symptoms, brain fog, and overall ...

A recent study suggests that liraglutide, a drug similar to Ozempic, may reduce migraine frequency in obese individuals with ...

Migraine treatment with topiramate is linked to lower risks of end-stage kidney disease (ESKD), death, and ventricular arrhythmia/cardiac arrest, an investigator reported at the 62 nd European Renal ...

A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

Already a household name in diabetes and weight management, Ozempic (semaglutide) may soon find another surprising role — as ...

Claire Szymanski woke one morning with what she thought was a "shocking" headache and four years on the pain has not stopped.

More than 37 million people in the United States suffer from migraines. If you’re one of them, you know they can be triggered ...

How Long Do Migraine Attacks Last? A migraine attack, by definition, lasts at least four hours and no more than 72 hours, ...